pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
Endpoints·May 6·1 min read
save

Former Orbital scientists launch new mRNA therapy startup

Two scientists think they've solved a technical problem that has kept the mRNA revolution from reaching its full potential. Now, they're launching ParcelBio with $13 million in seed funding to develop drugs based on their ...

May 6, 2026·read at Endpoints ↗

ParcelBio co-founders Chris Carlson (L) and David Weinberg May 6, 2026 11:17 AM EDT R&DCell/Gene Tx Ex­clu­sive: Start­up aims to lift mR­NA out of pur­ga­to­ry with more durable ther­a­pies Ryan Cross Senior Science Correspondent Two sci­en­tists think they’ve solved a tech­ni­cal prob­lem that has kept the mR­NA rev­o­lu­tion from reach­ing its full po­ten­tial. Now, they’re launch­ing Parcel­Bio with $13 … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER

source

Reporting by Endpoints.

read at Endpoints ↗
94 words · retrieved May 6
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
Moderna, Inc.2
topics
mRNA Therapeutic2

related stories

  • 4h agoNovartis may cut around 130 in Switzerland while relocating biologics productionBioSpace
  • Jul 23FDA panel confronting peptide controversySTAT
  • Jul 20Opinion: It’s time to treat pandemics as threats to national securitySTAT
  • Jul 17Arbutus, Sanofi escalate mRNA patent fights; InnoCare’s TYK2 contender advancesBioPharma Dive
  • Jul 16‘Substantially better than before’: Why India has golden opportunity to build on innovative R&D winsFierce Biotech